HLB Therapeutics a company specializing in the clinical development of new drugs, has both a sharp eye to identify competitive pipelines and an exceptional infrastructure to globally develop and commercialize such new drug opportunities.
By recruiting and retaining talented personnel, we have the expertise to directly manage organizations that engage in specialized clinical research, as well as organizations in charge of manufacturing. HLB Therapeutics’s business model seeks to increase the value of the Company and realize the profits of investors through licenses and dealing with multinational pharmaceutical companies after the development is completed. The Company wants to contribute health solutions through the development of new drugs for patients who are suffering. Although there are many difficulties in achieving success in our global clinical studies, HLB Therapeutics is committed to becoming an international leader in the field of drug development in the near future through diversification and competitiveness.
Thank you.
CEO: Ahn, Ki Hong
